In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

DOI Web Site 被引用文献4件
  • Nathaniel S. Hwang
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and
  • Shyni Varghese
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and
  • H. Janice Lee
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and
  • Zijun Zhang
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and
  • Zhaohui Ye
    Institute for Cell Engineering, and
  • Jongwoo Bae
    Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231
  • Linzhao Cheng
    Institute for Cell Engineering, and
  • Jennifer Elisseeff
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and

説明

<jats:p>Development of clinically relevant regenerative medicine therapies using human embryonic stem cells (hESCs) requires production of a simple and readily expandable cell population that can be directed to form functional 3D tissue in an in vivo environment. We describe an efficient derivation method and characterization of mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing fat, cartilage, and bone in vitro. Furthermore, we highlight their in vivo survival and commitment to the chondrogenic lineage in a microenvironment comprising chondrocyte-secreted morphogenetic factors and hydrogels. Normal cartilage architecture was established in rat osteochondral defects after treatment with chondrogenically-committed hESCd-MSCs. In view of the limited available cell sources for tissue engineering applications, these embryonic-derived cells show significant potential in musculoskeletal tissue regeneration applications.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ